Vera Bril
Active 1983–2025
- 144
- Papers
- 20,089
- Citations
- 75
- h-index
- 137
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine83%
- Biochemistry, Genetics and Molecular Biology8.5%
- Neuroscience2.7%
- Immunology and Microbiology2.1%
- Health Professions1%
- Engineering0.8%
- Other1.9%
Topics
- Pain Mechanisms and Treatments9.5%
- Peripheral Neuropathies and Disorders6.4%
- Myasthenia Gravis and Thymoma6.1%
- Diabetic Foot Ulcer Assessment and Management3.8%
- Botulinum Toxin and Related Neurological Disorders3.2%
- Peripheral Nerve Disorders2.4%
- Other68.6%
Coauthors
- Bruce A. Perkins30
- Carolina Barnett26
- Hans Katzberg18
- Leif E. Lovblom16
- Renato Mantegazza16
- Tuan Vu13
- Kimiaki Utsugisawa11
- Alon Abraham10
- Ari Breiner10
- Deepak Menon10
- Eva L. Feldman9
- Ingemar S. J. Merkies9
- James F. Howard9
- Andrej Orszag8
- Ali A. Habib7
- Eduardo Ng7
- Franz Woltering7
- Hiroyuki Murai7
- John Vissing7
- Madeline Ngo7
- Rayaz A. Malik7
- Andrew J.M. Boulton6
- Bernhard Greve6
- Dan Ziegler6
All papers
- Diabetic Neuropathy: A Position Statement by the American Diabetes Association
Authors: Rodica Pop‐Busui, Andrew J.M. Boulton, Eva L. Feldman, Vera Bril, Roy Freeman, Rayaz A. Malik, Jay M. Sosenko, Dan Ziegler - Diabetes Care 2016 cited by 2,466
- Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
Authors: James F. Howard, Vera Bril, Tuan Vu, Chafic Karam, Stojan Perić, Temur Margania, Hiroyuki Murai, Małgorzata Bilińska, R Shakarishvili, Marek Śmiłowski, Antonio Guglietta, Peter Ulrichts, Tony Vangeneugden, Kimiaki Utsugisawa, Jan J.G.M. Verschuuren, Renato Mantegazza, Jan L. De Bleecker, Kathy de Koning, Katrien De Mey, Annelien De Pue, R. Mercelis, Maren Wyckmans, Caroline Vinck, Linda Wagemaekers, Jonathan Baets, Eduardo Ng, Jafar Shabanpour, Lubna Daniyal, Shabber Mannan, Hans Katzberg, Angela Genge, Zaeem A. Siddiqi, Jana Junkerová, Jana Hořáková, Katerina Reguliova, Michaela Týblová, Ivana Jurajdova, Iveta Nováková, Michala Jakubíková, Jiří Piťha, Stanislav Voháňka, Katerina Havelkova, Tomáš Horák, Josef Bednařík, Mageda Horakova, Andreas Meisel, Dike Remstedt, Claudia Heibutzki, Siegfried Köhler, Lea Gerischer, Sarah Hoffman, Frauke Stascheit, John Vissing, Lizzie Zafirakos, Kuldeep Kumar Khatri, Anne Ostergaard Autzen, Mads Stemmerik, Henning Andersen, Shahram Attarian, Emmanuelle Salort‐Campana, Émilien Delmont, Aude‐Marie Grapperon, Ludivine Kouton, Alexander Tsiskaridze, Csilla Rózsa, Gedeonne Jakab, Szilvia Z. Tóth, G Szabó, David Bors, Enikő Szabó, Angela Campanella, Fiammetta Vanoli, Rita Frangiamore, Carlo Antozzi, Silvia Bonanno, Lorenzo Maggi, Riccardo Giossi, Francesco Saccà, Angela Marsili, Chiara Pane, Giorgia Puorro, Antonio Reia, Giovanni Antonini, Girolamo Alfieri, Stefania Morino, Matteo Garibaldi, Laura Fionda, Luca Leonardi, Shingo Konno, Akiyuki Uzawa, Kaoru Sakuma, Chiho Watanabe, Yukiko Ozawa, Manato Yasuda, Yosuke Onishi, Makoto Samukawa, Tomoko Tsuda, Yasushi Suzuki, Sayaka Ishida, Genya Watanabe and 118 more - The Lancet Neurology 2021 cited by 668
- Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
Authors: James F. Howard, Kimiaki Utsugisawa, Michael Benatar, Hiroyuki Murai, Richard J. Barohn, Isabel Illa, Saiju Jacob, John Vissing, Ted M. Burns, John T. Kissel, Srikanth Muppidi, Richard J. Nowak, Fanny O’Brien, Jingjing Wang, Renato Mantegazza, Claudio Mazia, Miguel Wilken, Carolina Ortea, Juliet Saba, Marcelo Rugiero, Mariela Bettini, Gonzalo Vidal, Alejandra Dalila Garcia, Phillipa J. Lamont, Wai-Kuen Leong, Heidi Boterhoven, Beverly Fyfe, L. Jackson Roberts, Mahi Jasinarachchi, Natasha Willlems, Julia Wanschitz, Wolfgang N. Löscher, Jan De Bleecker, Guy Van den Abeele, Kathy de Koning, Katrien De Mey, Rudy Mercelis, Linda Wagemaekers, Délphine Mahieu, Philip Van Damme, Charlotte Smetcoren, Olivier Stevens, Sarah Verjans, Ann D’Hondt, Petra Tilkin, Alzira Alves de Siqueira Carvalho, Rosa Hasan, Igor Dias Brockhausen, David Feder, Daniel Ambrosio, Ana Paula Souto Melo, Rosana Rocha, Bruno Bezerra Rosa, Thabata Veiga, Luiz Augusto da Silva, Jordana Gonçalves Geraldo, Maria da Penha Morita Ananias, Érica Nogueira Coelho, Gabriel Pina Paiva, M Tovar Pozo, Natália Prando, Debora Dada Martineli Torres, Cristiani Fernanda Butinhao, Érica Nogueira Coelho, Luciana Renata Cubas Volpe, Gustavo Duran, Tamires Cristina Gomes da Silva, Luiz Otavio Maia Gonçalves, Lucas Eduardo Pazetto, Luciana Souza Duca, Tomás Augusto Suriane Fialho, Maurício Friedrich, Alexandre Guerreiro, Henrique Mohr, Maurer Pereira Martins, Daiane da Cruz Pacheco, Ana Paula Macagnan, Aline de Cassia Santos, Acary Souza Bullé Oliveira, Ana Carolina Amaral de Andrade, Marcelo Annes, Valéria Cavalcante Lino, Wladimir Bocca Vieira de Rezende Pinto, Carolina Miranda, Fernanda Carrara, Iandra Souza, Angela Genge, Rami Massie, Natasha Campbell, Vera Bril, Hans Katzberg, Mehran Soltani, Eduardo Ng, Zaeem A. Siddiqi, Celile Phan, Derrick Blackmore, Stanislav Voháňka, Josef Bednařík, Magda Chmelikova, Marek Čierny and 524 more - The Lancet Neurology 2017 cited by 800
- Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
Authors: Vera Bril, Artur Drużdż, Julian Großkreutz, Ali A. Habib, Renato Mantegazza, Sabrina Sacconi, Kimiaki Utsugisawa, John Vissing, Tuan Vu, Marion Boehnlein, Ali Bozorg, Maryam Gayfieva, Bernhard Greve, Franz Woltering, Henry J. Kaminski, Angela Genge, Rami Massie, Maxime D. Bérubé, Vera Bril, Lubna Daniyal, Shabber Mannan, Eduardo Ng, Ritesh Rohan Raghu Raman, Evelyn Sarpong, Mónica Alcántara, Annie Dionne, Zaeem A. Siddiqi, Derrick Blackmore, Faraz Hussain, Geneviève Matte, Stéphan A. Botez, Michaela Týblová, Michala Jakubíková, Jana Junkerová, John Vissing, Nanna Witting, Sonja Holm‐Yildiz, Mads Stemmerik, Henning Andersen, Izabella Obál, Guilhem Solé, Stéphane Mathis, Marie‐Hélène Violleau, Christine Tranchant, Sihame Messai, Jean‐Baptiste Chanson, Aleksandra Nadaj‐Pakleza, Arnaud Verloes, Leila Zaidi, Sabrina Sacconi, Manuela Gambella, Michele Cavalli, Tanya Stojkovic, Sophie Demeret, Loïc Le Guennec, Giorgia Querin, Nicolas Weiss, Marion Masingue, Laurent Magy, Karima Ghorab, Ia Rukhadze, Alexander Tsiskaridze, Marina Janelidze, Temur Margania, Florian Then Bergh, Eike Hänsel, Andrea Kalb, Bianca Meilick, Mandy Reuschel, Lars-Malte Teußer, Astrid Unterlauft, Clemens Goedel, Tim Hagenacker, Andreas Totzeck, Benjamin Stolte, Franz Blaes, Christine Bindler, Vasilios Tsoutsikas, Annekathrin Roediger, Christian Geis, Jens Schmidt, Jana Zschüntzsch, Margret Schwarz, Stefanie Meyer, Karsten Kummer, Stefanie Glaubitz, Rachel Zeng, Heinz Wiendl, Luisa Klotz, Anna Lammerskitten, Jan D. Lünemann, Péter Diószeghy, Renato Mantegazza, Lorenzo Maggi, Elena Rinaldi, Matteo Gastaldi, Federico Mazzacane, Pietro Businaro, Raffaele Iorio, Giovanni Antonini and 193 more - The Lancet Neurology 2023 cited by 260
- Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy
Authors: Teresa Coelho, Wilson Marques, Noel R. Dasgupta, Chi‐Chao Chao, Yeşim Parman, Marcondes C. França, Yuh‐Cherng Guo, Jonas Wixner, Long‐Sun Ro, Cristian Calandra, Pedro André Kowacs, John L. Berk, Laura Obici, Fábio Barroso, Markus Weiler, Isabel Conceição, Shiangtung W. Jung, Gustavo Büchele, Michela Brambatti, Jersey Chen, Steven G. Hughes, Eugene Schneider, Nicholas J. Viney, Ahmad Masri, Morie R. Gertz, Yukio Ando, Julian D. Gillmore, Sami Khella, P. James B. Dyck, Márcia Waddington‐Cruz, NEURO-TTRansform Investigators, Anna Mazzeo, Aikaterini Papagianni, Mazen M. Dimachkie, Ioannis Zaganas, Edward Gane, Marco Luigetti, Lucía Galán Dávila, Michelle M. Mezei, Juan González Moreno, Pascal Cintas, Davide Pareyson, Rebecca Traub, Julie Khoury, Conrado J. Estol, Merrilee Needham, David Adams, Michael Polydefkis, Thomas H. Brannagan, Vera Bril, Shahram Attarian, Marcelo Rugiero, B. Jane Distad, Eleni Zamba Papanicolaou, Kon‐Ping Lin, Merrill D. Benson, Morton Scheinberg - JAMA 2023 cited by 207
- Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
Authors: James F. Howard, Vera Bril, Ted M. Burns, Renato Mantegazza, Małgorzata Bilińska, Andrzej Szczudlik, Said R. Beydoun, Francisco Javier Rodríguez de Rivera Garrido, Fredrik Piehl, Mariarosa Rottoli, Philip Van Damme, Tuan Vu, Amelia Evoli, Miriam Freimer, Tahseen Mozaffar, E. Sally Ward, Torsten Dreier, Peter Ulrichts, Katrien Verschueren, Antonio Guglietta, Hans de Haard, Nicolas Leupin, Jan J.G.M. Verschuuren, on behalf of the Efgartigimod MG Study Group, on behalf of the Efgartigimod MG Study Group, Kristl G. Claeys, Veena Mathew, Manlio Sgarzi, Exuperio Díez‐Tejedor, Brittany Leigh Harvey, Jerrica Farias, Rita Frangiomore, Sarah Heintsman, Robert H.P. de Meel, Manisha Chopra, Paolo Emilio Alboini, Angela Genge - Neurology 2019 cited by 288
- Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals
Authors: Deepak Menon, Vera Bril - Drugs 2022 cited by 129
- Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis
Authors: Vera Bril, Michael Benatar, Henning Andersen, John Vissing, Melissa Brock, Bernhard Greve, Peter Kießling, Franz Woltering, Laura E. Griffin, Peter Van den Bergh, on behalf of the MG0002 Investigators Josef Benarik Said Beydoun Dr Franz Blaes Prof. Jan De Bleecker Prof. Miriam Freimer Dr Angela Genge Dr Julian Grosskreutz Dr Antonio Guerrero Sola Dr Jeffrey Guptill Dr Isabel Illa Sendra Prof. Sebastian Jander Dr Jana Junkerova Dr Tahseen Mozaffar Dr Michael Nicolle Dr Michael Rivner Prof. Philip Van Damme Dr Tuan Vu Dr Björn Tackenberg Dr Jan Thomsen Dr Stanislav Vohanka Dr Magda Horakova Dr Thomas Horak Dr Volkan Granit Dr Frank Lin Dr Nazila Rad Dr John - Neurology 2020 cited by 140
- Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
Authors: James F. Howard, Vera Bril, Tuan Vu, Chafic Karam, Stojan Perić, Jan De Bleecker, Hiroyuki Murai, Andreas Meisel, Said R. Beydoun, Mamatha Pasnoor, Antonio Guglietta, Benjamin Van Hoorick, Sophie Steeland, Caroline T’joen, Kimiaki Utsugisawa, Jan J.G.M. Verschuuren, Renato Mantegazza, the ADAPT+ Study Group - Frontiers in Neurology 2024 cited by 71
- Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary
Authors: Raymond Price, Don Smith, Gary Franklin, Gary Gronseth, Michael Pignone, William S. David, Carmel Armon, Bruce A. Perkins, Vera Bril, Alexander Rae-Grant, John Halperin, Nicole Licking, Mary Dolan O'Brien, Scott R. Wessels, Leslie C. MacGregor, Kenneth Fink, Lawrence B. Harkless, Lindsay Colbert, Brian C. Callaghan - Neurology 2021 cited by 167
- Diabetic Neuropathies
Authors: Andrew J.M. Boulton, A Vinik, Joseph C. Arezzo, Vera Bril, Eva L. Feldman, Roy Freeman, Rayaz A. Malik, Raelene E. Maser, Jay M. Sosenko, Dan Ziegler - Diabetes Care 2005 cited by 1,836
- International clinimetric evaluation of the MG‐QOL15, resulting in slight revision and subsequent validation of the MG‐QOL15r
Authors: Ted M. Burns, Reza Sadjadi, Kimiaki Utsugisawa, Kelly Gwathmey, Amruta Joshi, Sarah Jones, Vera Bril, Carolina Barnett, Jeffrey T. Guptill, Donald B. Sanders, Lisa D. Hobson‐Webb, Vern C. Juel, Janice M. Massey, Karissa Gable, Nicholas J. Silvestri, Gil I. Wolfe, Gary Cutter, Yuriko Nagane, Hiroyuki Murai, Masayuki Masuda, Maria Elena Farrugia, Caroline Carmichael, Simone Birnbaum, Jean‐Yves Hogrel, Shahriar Nafissi, Farzad Fatehi, Changyi Ou, Weibin Liu, Mark R. Conaway - Muscle & Nerve 2016 cited by 156
- Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders
Authors: Jan J.G.M. Verschuuren, Jacqueline Palace, Hiroyuki Murai, Martijn R. Tannemaat, Henry J. Kaminski, Vera Bril - The Lancet Neurology 2022 cited by 108
- Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis
Authors: Carlo Antozzi, Jeffrey T. Guptill, Vera Bril, Josep Gámez, Sven G. Meuth, Richard J. Nowak, Dianna Quan, Teresa Sevilla, Marie‐Hélène Jouvin, Jim Y. Jin, Keith Karcher, Sindhu Ramchandren, Hong Sun, Leona Ling, Yaowei Zhu, Santiago Arroyo, for the Vivacity-MG Phase 2 Study Group - Neurology 2023 cited by 72
- Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity
Authors: Peter James Dyck, James W. Albers, Henning Andersen, Joseph C. Arezzo, Geert‐Jan Biessels, Vera Bril, Eva L. Feldman, William J. Litchy, Peter C. O’Brien, James W. Russell, on behalf of The Toronto Expert Panel on Diabetic Neuropathy - Diabetes/Metabolism Research and Reviews 2011 cited by 492
- Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis
Authors: K. Hewett, Donald B. Sanders, Richard Grove, Christine L. Broderick, Todd Rudo, Ashlyn Bassiri, Marina Zvartau‐Hind, Vera Bril, On behalf of the BEL115123 Study Group, BEL115123 Study Group, Laurence Adams, Sankar Bandyopadhyay, Said R. Beydoun, Felix Bischof, Mazen M. Dimachkie, Miriam Freimer, Maurizio Inghilleri, Henry J. Kaminski, Renato Mantegazza, Tahseen Mozaffar, Michael Nicolle, Khema R. Sharma, Zaeemi Siddiqi, Ericka Simpson, Florian Then Bergh, Tuan Vu, Radwa Aly, Carlo Antozzi, Richard J. Barohn, Derrick Blackmore, Silvia Bonanno, Angela Campanella, Tiyonnoh Cash, Bakri Elsheikh, Vittorio Frasca, Namita Goyal, Brittany Harvey, Eugene C. Lai, Lorenzo Maggi, Brian Minton, Verónica Puertas‐Martín, Emanuela Onesti, Mamatha Pasnoor, Gulmohor Roy, Sheetal Shroff, Jason R. Thonhoff - Neurology 2018 cited by 128
- Evidence-based guideline: Treatment of painful diabetic neuropathy [RETIRED]
Authors: Vera Bril, J. England, Gary M. Franklin, Miroslav Bačkonja, J. A. Cohen, David Del Toro, Eva L. Feldman, Donald Iverson, Bruce A. Perkins, James W. Russell, Douglas W. Zochodne - Neurology 2011 cited by 630
- Comparison of IVIg and PLEX in patients with myasthenia gravis
Authors: David Barth, Maryam Nabavi Nouri, E. Ng, P. Nwe, Vera Bril - Neurology 2011 cited by 351
- Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
Authors: Ivo N. van Schaik, Vera Bril, Nan van Geloven, Hans‐Peter Hartung, Richard A. Lewis, Gen Sobue, John‐Philip Lawo, Michaela Praus, Orell Mielke, Billie L. Durn, David R. Cornblath, Ingemar S. J. Merkies, Arman Sabet, Koshy George, L. Jackson Roberts, Ross Carne, Stefan Blum, Robert D. Henderson, Philip Van Damme, Jelle Demeestere, Sandrine Larue, Catherine-Andree Pinard D'Amour, Vera Bril, Ari Breiner, Pavel Kunc, Martin Vališ, J Süssová, Tomas Kalous, Radomír Taláb, Michal Bednar, Toomas Toomsoo, Inna Rubanovits, Katrin Gross‐Paju, Ulvi Sorro, M. Saarela, Mari Auranen, Jean Pouget, Shahram Attarian, Gwendal Le Masson, Anne-Cécile Wielanek-Bachelet, Claude Desnuelle, Émilien Delmont, Pierre Clavelou, D Aufauvre, Jens Schmidt, Jana Zschuentssch, Claudia Sommer, Daniela Kramer, Olaf Hoffmann, Carsten Goerlitz, Jürgen Haas, Marios Chatzopoulos, Richard S. Yoon, Ralf Gold, Peter Berlit, Andrea Jaspert-Grehl, David Liebetanz, Anna Kutschenko, Martin Stangel, Corinna Trebst, Petra Baum, Florian Then Bergh, Juliane Klehmet, Andreas Meisel, Fabian Klostermann, Johanna Oechtering, Helmar C. Lehmann, Michael Schroeter, Tim Hagenacker, Daniel Mueller, A.D Sperfeld, F. Bethke, Vivian E. Drory, Avi A. Algom, David Yarnitsky, Beth B. Murinson, Antonio Di Muzio, Fausta Ciccocioppo, Sandro Sorbi, Sabrina Matà, Angelo Schenone, Marina Grandis, Giuseppe Lauria, Daniele Cazzato, Giovanni Antonini, Stefania Morino, Dario Cocito, Maurizio Zibetti, Takanori Yokota, Takuya Ohkubo, Takashi Kanda, M Kawai, Kenichi Kaida, Hiroyuki Onoue, Satoshi Kuwabara, Masahiro Mori, Masahiro Iijima, Ken Ohyama, Masayuki Baba, Masahiko Tomiyama and 50 more - The Lancet Neurology 2017 cited by 269
- Validation of the Toronto Clinical Scoring System for Diabetic Polyneuropathy
Authors: Vera Bril, Bruce A. Perkins - Diabetes Care 2002 cited by 457
- Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial
Authors: Richard AC Hughes, Peter D. Donofrio, Vera Bril, Marinos C. Dalakas, C. Q. Deng, Kim Hanna, Hans‐Peter Hartung, Norman Latov, Ingemar S. J. Merkies, Pieter A. van Doorn - The Lancet Neurology 2008 cited by 669
- Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy
Authors: Vera Bril, Sasagu Tomioka, R. A. Buchanan, Bruce A. Perkins, the mTCNS Study Group - Diabetic Medicine 2009 cited by 220
- Novel Treatments in Myasthenia Gravis
Authors: Deepak Menon, Carolina Barnett, Vera Bril - Frontiers in Neurology 2020 cited by 101
- The genomic landscape of schwannoma
Authors: Sameer Agnihotri, Shahrzad Jalali, Mark R. Wilson, Arnavaz Danesh, Mira Li, George Klironomos, Jonathan R. Krieger, Alireza Mansouri, Osaama H. Khan, Yasin Mamatjan, Natalie Landon‐Brace, Takyee Tung, Mark Dowar, Tiantian Li, Jeffrey P. Bruce, Kelly Burrell, Peter D. Tonge, Amir Alamsahebpour, Boris Krischek, Pankaj K. Agarwalla, Wenya Linda Bi, Ian F. Dunn, Rameen Beroukhim, Michael G. Fehlings, Vera Bril, Stefano Maria Pagnotta, Antonio Iavarone, Trevor J. Pugh, Kenneth Aldape, Gelareh Zadeh - Nature Genetics 2016 cited by 188
